All Regulation articles – Page 10
-
BusinessUK grants Pfizer–BioNTech Covid-19 vaccine emergency approval
Regulators around the world working towards accelerated decisions on vaccine data
-
BusinessBrexit may put some chemicals out of GB’s Reach
Industry fears divergence of UK and EU regulations could spell disaster for trade
-
-
NewsEuropeans want nanomaterial products to be labelled, survey shows
While awareness of nanomaterials in everyday products remains low, 87% of people want them noted, surveys in five European countries shows
-
BusinessRegulatory panel unconvinced by Alzheimer’s antibody evidence
US FDA advisors vote against approving Biogen’s aducanumab on the basis of incomplete data analysis
-
NewsFresh calls for EU to review gene-edited crops regulations
Outdated legislation is hampering innovation and sustainability efforts, argue crop scientists
-
OpinionA promising peep at Covid-19 vaccine efficacy
Pfizer–BioNTech’s will need to be one of many if we are to overcome the pandemic
-
BusinessEarly indications suggest Pfizer–BioNTech’s Covid-19 vaccine is effective
Company claims 90% efficacy at preventing disease, but experts call for data rather than press releases
-
BusinessEU commits to overhaul of chemicals legislation
The Chemicals Strategy for Sustainability promises the biggest reform since Reach
-
BusinessCovid-19 highlights need to update pharma supply chains
Resilience and redundancy are key amid protectionist calls for domestic manufacturing
-
NewsChemistry at work in e-liquids is still poorly understood, worrying researchers
New compounds with potentially harmful effects on the lungs can form from the mixture of flavours and solvents – even at room temperature
-
WebinarThe circular economy data challenge
Join us to gain a deeper understanding of the chemistry-focused data challenges in commercial circular economies
-
OpinionJumping the vaccine queue
Deals between companies and rich governments offset manufacturing risks, but must not compromise supplies to those in need
-
BusinessCovid-19 vaccine deals risk skewing supply
International accords including Covax aiming to ensure equitable distribution to poorer countries
-
BusinessRussian Covid-19 vaccine data raises questions
Suspected data manipulation or fabrication casts shadows over safety trial report for hastily-approved Sputnik V
-
BusinessUncovering the sources of contaminated sanitisers
Methanol and 1-propanol could get into hand gels by unintentional or deliberate adulteration
-
OpinionFacing the challenge of vaccine trials
Russia’s Covid-19 gamble is a stark contrast to even accelerated clinical programmes
-
OpinionFrom collaboration to collusion
The US government’s crackdown on academics not declaring Chinese funding highlights a moral hazard
-
NewsEPA rescinds methane emissions reduction rule
Obama-era regulations have been rolled back at the EPA, to the chagrin of some big oil firms and environmental groups
-
BusinessOvercoming hydrogen hype
European strategies set up hydrogen’s potential contribution to lowering carbon emissions